These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12383943)

  • 1. Increased dopamine peroxidation in postmortem Parkinsonian brain.
    De Iuliis A; Burlina AP; Boschetto R; Zambenedetti P; Arslan P; Galzigna L
    Biochim Biophys Acta; 2002 Oct; 1573(1):63-7. PubMed ID: 12383943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rat brain fraction and different purified peroxidases catalyzing the formation of dopaminochrome from dopamine.
    Galzigna L; Schiappelli MP; Rigo A; Scarpa M
    Biochim Biophys Acta; 1999 May; 1427(3):329-36. PubMed ID: 10350648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative metabolism of dopamine: a colour reaction from human midbrain analysed by mass spectrometry.
    De Iuliis A; Arrigoni G; Andersson L; Zambenedetti P; Burlina A; James P; Arslan P; Vianello F
    Biochim Biophys Acta; 2008 Nov; 1784(11):1687-93. PubMed ID: 18675943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic oxidation of dopamine: the role of prostaglandin H synthase.
    Hastings TG
    J Neurochem; 1995 Feb; 64(2):919-24. PubMed ID: 7830086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, redox properties, in vivo formation, and neurobehavioral effects of N-acetylcysteinyl conjugates of dopamine: possible metabolites of relevance to Parkinson's disease.
    Shen XM; Xia B; Wrona MZ; Dryhurst G
    Chem Res Toxicol; 1996; 9(7):1117-26. PubMed ID: 8902266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease.
    Afonso-Oramas D; Cruz-Muros I; Alvarez de la Rosa D; Abreu P; Giráldez T; Castro-Hernández J; Salas-Hernández J; Lanciego JL; Rodríguez M; González-Hernández T
    Neurobiol Dis; 2009 Dec; 36(3):494-508. PubMed ID: 19766189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in peptide levels in Parkinson's disease and incidental Lewy body disease.
    Fernandez A; de Ceballos ML; Rose S; Jenner P; Marsden CD
    Brain; 1996 Jun; 119 ( Pt 3)():823-30. PubMed ID: 8673494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peculiarities of L: -DOPA treatment of Parkinson's disease.
    Kostrzewa RM; Nowak P; Kostrzewa JP; Kostrzewa RA; Brus R
    Amino Acids; 2005 Mar; 28(2):157-64. PubMed ID: 15750845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains.
    Smith Y; Villalba R
    Mov Disord; 2008; 23 Suppl 3():S534-47. PubMed ID: 18781680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.
    Kim SE; Choi JY; Choe YS; Choi Y; Lee WY
    J Nucl Med; 2003 Jun; 44(6):870-6. PubMed ID: 12791812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of dopamine--DNA adducts: potential role in Parkinson's disease.
    Lévay G; Bodell WJ
    Carcinogenesis; 1993 Jun; 14(6):1241-5. PubMed ID: 8508513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease. Possible neuroprotective role of DT-diaphorase.
    Graumann R; Paris I; Martinez-Alvarado P; Rumanque P; Perez-Pastene C; Cardenas SP; Marin P; Diaz-Grez F; Caviedes R; Caviedes P; Segura-Aguilar J
    Pol J Pharmacol; 2002; 54(6):573-9. PubMed ID: 12866711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
    Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
    Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the alpha-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease.
    Shen XM; Li H; Dryhurst G
    J Neural Transm (Vienna); 2000; 107(8-9):959-78. PubMed ID: 11041275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous morphine-like compound immunoreactivity increases in parkinsonism.
    Charron G; Doudnikoff E; Laux A; Berthet A; Porras G; Canron MH; Barroso-Chinea P; Li Q; Qin C; Nosten-Bertrand M; Giros B; Delalande F; Van Dorsselaer A; Vital A; Goumon Y; Bezard E
    Brain; 2011 Aug; 134(Pt 8):2321-38. PubMed ID: 21742735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine Is Required for the Neural Representation and Control of Movement Vigor.
    Panigrahi B; Martin KA; Li Y; Graves AR; Vollmer A; Olson L; Mensh BD; Karpova AY; Dudman JT
    Cell; 2015 Sep; 162(6):1418-30. PubMed ID: 26359992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis.
    Li SW; Lin TS; Minteer S; Burke WJ
    Brain Res Mol Brain Res; 2001 Sep; 93(1):1-7. PubMed ID: 11532332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-derived dopaminochrome promotes H(2)O(2) release at mitochondrial complex I: stimulation by rotenone, control by Ca(2+), and relevance to Parkinson disease.
    Zoccarato F; Toscano P; Alexandre A
    J Biol Chem; 2005 Apr; 280(16):15587-94. PubMed ID: 15710606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.
    Madras BK; Gracz LM; Fahey MA; Elmaleh D; Meltzer PC; Liang AY; Stopa EG; Babich J; Fischman AJ
    Synapse; 1998 Jun; 29(2):116-27. PubMed ID: 9593102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical aspects of Parkinson's disease.
    Hornykiewicz O
    Neurology; 1998 Aug; 51(2 Suppl 2):S2-9. PubMed ID: 9711973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.